TG Therapeutics, Inc. (TGTX)
40.93
+0.77
(+1.92%)
USD |
NASDAQ |
Jun 08, 16:00
40.93
0.00 (0.00%)
After-Hours: 18:36
TG Therapeutics Market Cap : 6.266B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 8.891B |
| MAIA Biotechnology, Inc. | 77.36M |
| Vericel Corp. | 1.825B |
| Catalyst Pharmaceuticals, Inc. | 3.822B |
| United Therapeutics Corp. | 22.96B |
Market Cap Related Metrics
| PE Ratio | 14.26 |
| PS Ratio | 9.394 |
| PEG Ratio | 0.0132 |
| Price to Book Value | 10.75 |
| Price | 40.93 |
| Earnings Yield | 7.01% |
| PEGY Ratio | 0.0132 |
| Operating PE Ratio | 44.01 |
| Normalized PE Ratio | 14.03 |